查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1568901

全球药品商业化解决方案与服务业，2024-2029

Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024-2029
出版日期: | 出版商: Frost & Sullivan | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

基于SaaS服务平台的创新精准行销和程序化行销方式加速医药商业化

随着越来越偏好以患者为中心的医疗保健提供方式，製药业正在透过清楚地了解市场相关人员、细分市场和上市后期望并製定无缝的打入市场策略来为市场商业化做好准备。为了应对不断变化的区域市场状况，製药公司正在与第三方物流合作，采用适应性供应链策略，例如双重采购、库存和先进的场景规划，同时降低分销风险。情况。因此，行销和销售策略旨在帮助製药公司应对相关人员、监管机构、最终用户和其他技术供应商的海洋。製药公司行销利用科学资料、推荐等在 HCP（医疗保健专业人员）中建立积极的药物采用率，以提高产品知名度并鼓励后续药物的采用，从而建立积极的形象和信任。製药公司正在采取逐步进入商业市场的方法，包括从根据产品的提案主张确定目标市场，到了解不断变化的最终用户观点，以及必须采取必要的改变来保持竞争优势。自动化和利用人工智慧、机器学习和云端解决方案将帮助製药公司扩大商业业务。这些工具使用预测分析来进行市场细分、内容个人化、潜在客户识别和评分以及随后的市场进入，从而确保更好的产品采用率和收益。製药公司和供应商必须专注于跨产业合作，以提高商业化成功率。该分析深入探讨了 HEOR 解决方案、量身定制/​​精准的全通路行销策略以及付款人和 PBM 的综合药品定价的市场机会，并按服务模式/合约类型对预测进行了细分。

目录

成长环境：医药商业化解决方案与服务领域的转型

  • 为什么成长如此困难？
  • The Strategic Imperative 8（TM）
  • 三大策略对医药商业化解决方案与服务业的影响

成长环境：医药商业化解决方案与服务的生态系统

  • 分析范围
  • 市场定义、范围和细分
  • 按商业服务模式/伙伴关係类型细分
  • 製药商业价值链 - 商业分析概述
  • 市场趋势分析
  • 生长促进因子
  • 成长抑制因素

成长环境：医药商业服务

  • 药品上市－关键业务和相关人员
  • 药品行销和销售的主要方面
  • 药品市场进入流程的主要方面
  • 供应商生态系统

成长环境：医药商业服务

  • 相关人员商业化的数位解决方案
  • 製药公司商业活动中技术的利用
  • 在价值链中利用人工智慧
  • 有效沟通的数位行销策略
  • 数位市场准入策略
  • 部署数位转型以实现以病人为中心的药物商业化

成长环境：医药商业服务

  • 投资趋势
  • 投资趋势 - 技术收购/伙伴关係
  • 投资趋势 - 策略伙伴关係
  • 投资趋势-併购
  • 新产品上市－业务拓展

成长环境：行动中的公司（C2A）、医药商业化解决方案与服务业部门

  • 竞争环境
  • 竞技评级纯玩
  • 竞争性评估CRO/CSO
  • 竞争评估技术推动者
  • 竞争评估

成长机会分析：药品商业化解决方案和服务业的成长要素

  • 成长指标
  • 预测考虑因素：途径和调查方法
  • 预测的考虑：局限性和注意事项
  • 收益和预测
  • 收益预测：按解决方案/服务类型
  • 收益预测分析
  • 收益预测：依服务模式/合约类型
  • 收益预测分析：依服务模式/合约类型

成长机会分析：药品商业化解决方案和服务业的成长要素

  • 区域趋势分析 - 北美
  • 区域趋势分析-欧洲
  • 区域趋势分析 - 亚太地区
  • 区域趋势分析 - 其他新兴市场

成长机会宇宙

  • 成长机会 1：HEOR 服务的多 AI 和 LLM 代理
  • 成长机会 2：针对 PBM 和付款人的综合药品定价策略
  • 成长机会3：精准行销与销售策略的创新方法

药品商业化解决方案和服务业最佳实践的评估

  • 最佳实践评估

用于药品商业化解决方案和服务业的FROST RADAR

  • FROST RADAR

下一步

  • 成长机会的好处和影响
  • 下一步
  • 图表列表
  • 免责声明
简介目录
Product Code: PFOW-52

Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market landscapes across geographies, pharma companies are collaborating with third-party logistics and adopting adaptive supply chain strategies, such as dual sourcing, stockpiling, and advanced scenario planning, while tapping into established distribution partners' capabilities to avoid distribution risks and disruptions. As a result, marketing and sales strategies are designed to allow pharma companies to navigate the sea of stakeholders, regulatory bodies, end users, and other technology vendors. To increase product awareness and subsequent uptake, pharma marketing creates a positive image and confidence amongst HCPs for drug adoption using scientific data, testimonials, and many more. Pharma companies will have to adopt a step-by-step approach toward commercial market access, which involves everything from identifying the target market based on the product value proposition to understanding changes in end-user perspective and making the necessary alterations to maintain a competitive edge. Automation and the use of AI, ML, and cloud solutions will be instrumental in upscaling pharma commercial operations. These tools use predictive analytics for market segmentation, content personalization, lead identification and scoring, and subsequent market access, thereby ensuring better product uptake and revenue. Pharma companies and vendors must look at industry cross-collaborations that will improve commercialization success. This analysis dives deep into market opportunities available in HEOR solutions, tailormade/precision omnichannel marketing strategies, and integrated drug pricing for payers and PBMs and categorizes forecasts by service model/agreement type.

Table of Contents

Growth Environment: Transformation in Pharmaceutical Commercialization Solutions and Services Sector

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Commercial Solutions and Services Industry

Growth Environment: Ecosystem in Pharmaceutical Commercialization Solutions and Services Sector

  • Scope of Analysis
  • Market Definition, Scope and Segmentation
  • Segmentation by Commercial Services Model/Partnership Type
  • Pharmaceutical Commercial Value Chain-Commercial Analytics Overview
  • Market Trend Analysis
  • Growth Drivers
  • Growth Restraints

Growth Environment: Pharmaceutical Commercial Services

  • Pharmaceutical Commercial Launch-Primary Operations and Stakeholders involved
  • Key Aspects of Pharmaceutical Marketing and Sales
  • Key Aspects of Pharmaceutical Market Access Process
  • Vendor Ecosystem

Growth Environment: Pharmaceutical Commercial Services

  • Digital Solutions for Commercialization by Stakeholders
  • Technology Application across Pharma Commercial Activities
  • AI Application across the Commercialization Value Chain
  • Digital Marketing Strategies for Effective Communication
  • Digital Market Access Strategies
  • Embracing Digital Transformation for Patient-centric Pharma Commercialization

Growth Environment: Pharmaceutical Commercial Services

  • Investment Trends
  • Investment Trends-Technology Acquisition/Partnerships
  • Investment Trends-Strategic Partnerships
  • Investment Trends-Mergers & Acquisitions
  • New Product Launches-Expansions

Growth Environment: Companies to Action (C2A), Pharmaceutical Commercial Solutions and Services Sector

  • Competitive Environment
  • Competitor Assessment: Pure Play
  • Competitor Assessment: CROs/CSOs
  • Competitor Assessment: Tech Enablers
  • Competitor Assessment

Growth Opportunity Analysis: Growth Generator in Pharmaceutical Commercial Solutions and Services Sector

  • Growth Metrics
  • Forecast Considerations: Approach and Methodology
  • Forecast Considerations: Limitations and Caveats
  • Revenue Forecast
  • Revenue Forecast by Solution/Services Type
  • Revenue Forecast Analysis
  • Revenue Forecast By Service Model/Agreement Type
  • Revenue Forecast Analysis By Service Model/Agreement Type

Growth Opportunity Analysis: Growth Generator in Pharmaceutical Commercial Solutions and Services Industry

  • Regional Trend Analysis-North America
  • Regional Trend Analysis-Europe
  • Regional Trend Analysis-Asia Pacific
  • Regional Trend Analysis-Other Emerging Markets

Growth Opportunity Universe

  • Growth Opportunity 1: Multi AI and LLM agents for HEOR Services
  • Growth Opportunity 2: Integrated Drug Pricing Strategies for PBMs and Payors
  • Growth Opportunity 3: Innovative Approaches for Precision Marketing and Sales Strategies

Best Practices Recognition in Pharmaceutical Commercialization Solutions and Services Sector

  • Best Practices Recognition

Frost Radar in Pharmaceutical Commercialization Solutions and Services Sector

  • Frost Radar

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • List of Exhibits
  • Legal Disclaimer